|
OriGene
flag tagged hectd1 ![]() Flag Tagged Hectd1, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/hectd1/HECTD1+(NM_015382)+Human+Tagged+ORF+Clone/pm34729249-182-0-5 Average 90 stars, based on 1 article reviews
flag tagged hectd1 - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Cusabio
anti hectd1 primary antibody ![]() Anti Hectd1 Primary Antibody, supplied by Cusabio, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/hectd1/Rabbit+anti-+HECTD1+Polyclonal+Antibody/pmc07115742-39-52-61 Average 91 stars, based on 1 article reviews
anti hectd1 primary antibody - by Bioz Stars,
2026-11
91/100 stars
|
Buy from Supplier |
|
ABclonal Biotechnology
huwe1 rabbit pab abclonal ![]() Huwe1 Rabbit Pab Abclonal, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/hectd1/HECTD1+Rabbit+pAb/pmc10680658__media___7-194-255-258 Average 91 stars, based on 1 article reviews
huwe1 rabbit pab abclonal - by Bioz Stars,
2026-11
91/100 stars
|
Buy from Supplier |
|
Proteintech
rabbit anti hectd1 pab ![]() Rabbit Anti Hectd1 Pab, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/hectd1/HECTD1+Antibody/pmc08943137-123-122-130 Average 93 stars, based on 1 article reviews
rabbit anti hectd1 pab - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Santa Cruz Biotechnology
crispr cas9 double nickase plasmids ![]() Crispr Cas9 Double Nickase Plasmids, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/hectd1/HECTD1+Double+Nickase+Plasmid/pmc06887829-58-0-15 Average 93 stars, based on 1 article reviews
crispr cas9 double nickase plasmids - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Santa Cruz Biotechnology
hectd1 crispr cas9 overexpression plasmid ![]() Hectd1 Crispr Cas9 Overexpression Plasmid, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/hectd1/HECTD1+CRISPR%2FCas9+KO+Plasmid/pmc06973311-120-1-8 Average 93 stars, based on 1 article reviews
hectd1 crispr cas9 overexpression plasmid - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Santa Cruz Biotechnology
anti hectd1 ![]() Anti Hectd1, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/hectd1/HECTD1+Antibody/pmc07904838-331-15-17 Average 93 stars, based on 1 article reviews
anti hectd1 - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
OriGene
hectd1 kd ![]() Hectd1 Kd, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/hectd1/HECTD1+Human+shRNA+Lentiviral+Particle/pmc07115742-26-4-28 Average 90 stars, based on 1 article reviews
hectd1 kd - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Fortis Life Sciences
a302 908a t ![]() A302 908a T, supplied by Fortis Life Sciences, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/hectd1/HECTD1+Antibody/pmc05738441-316-45-44 Average 91 stars, based on 1 article reviews
a302 908a t - by Bioz Stars,
2026-11
91/100 stars
|
Buy from Supplier |
|
Novus Biologicals
anti hectd1 ![]() Anti Hectd1, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/hectd1/HECTD1+Antibody+(1C7)/pmc06361158-257-35-36 Average 90 stars, based on 1 article reviews
anti hectd1 - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Santa Cruz Biotechnology
hectd1 ![]() Hectd1, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/hectd1/HECTD1+siRNA/pm35701426-378-13-39 Average 90 stars, based on 1 article reviews
hectd1 - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Santa Cruz Biotechnology
hectd1 crispr activation plasmid ![]() Hectd1 Crispr Activation Plasmid, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/hectd1/HECTD1+CRISPR+Activation+Plasmid/pmc05852113-80-1-15 Average 93 stars, based on 1 article reviews
hectd1 crispr activation plasmid - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Molecular therapy. Nucleic acids
Article Title: Overexpression of BIRC6 driven by EGF-JNK-HECTD1 signaling is a potential therapeutic target for triple-negative breast cancer.
doi: 10.1016/j.omtn.2021.09.011
Figure Lengend Snippet: Figure 3. HECTD1 promotes BIRC6 ubiquitination and degradation during EGFR activation (A) Coomassie blue staining of proteins co-precipitated with an anti-Myc or anti-BIRC6 antibody. Bottom: the number of unique peptides of HECTD1 identified by mass spectrometric analysis. (B) Hs578T cell lysates were immunoprecipitated with an HECTD1 antibody and subjected to immunoblotting analysis. (C) Hs578T cells expressing Flag-tagged HECTD1 were treated with or without MG132 for 8 h and then immunoblotted with the indicated antibodies. (D) Hs578T cells expressing Flag-tagged HECTD1 were treated with CHX (100 mg/mL) for the indicated times, followed by immunoblotting as indicated. (E) Scramble or HECTD1-knockdown Hs578T cells were treated with CHX (100 mg/mL) for the indicated times and then immunoblotted with the indicated antibodies. (F) After being transiently transfected with the indicated plasmids, 293T cells were immunoprecipitated with an anti-Myc antibody and then subjected to immunoblotting analysis. Cells were treated with 10 mM MG132 for 6 h before being lysed. (G) Scramble or HECTD1-knockdown Hs578T cells were immunoprecipitated with an anti-BIRC6 antibody and subjected to ubiquitination analysis. (H) After being serum starved overnight, scramble or HECTD1-knockdown Hs578T cells were treated with EGF for 30 min, followed by immunoblotting as indicated. (I) After being treated with or without EGF, Hs578T cells were immunoprecipitated with an anti-HECTD1 antibody and subjected to immunoblotting analysis.
Article Snippet:
Techniques: Ubiquitin Proteomics, Activation Assay, Staining, Immunoprecipitation, Western Blot, Expressing, Knockdown, Transfection
Journal: International Journal of Oncology
Article Title: HECTD1 regulates the expression of SNAIL: Implications for epithelial-mesenchymal transition
doi: 10.3892/ijo.2020.5002
Figure Lengend Snippet: Interaction of HECTD1 with SNAIL. (A) In vivo interaction of HECTD1 with SNAIL. The interaction between HECTD1 and SNAIL expression levels were investigated using Co-Immunoprecipitation. HeLa cells were transfected with GFP-tagged SNAIL or GFP for 24 h, followed by sequential treatment with DMSO or 5 µM MG132 for 16 h. The cell lysates were immunoprecipitated with anti-GFP. IPs and WCLs were analyzed using western blotting to detect the expression levels of HECTD1 and GFP. (B) SNAIL ubiquitination assay. HeLa Ctrl and HECTD1-KD cells were transiently transfected with GFP-SNAIL or GFP empty vector for 24 h, followed by sequential treatment with DMSO or 5 µM MG132 for 16 h. The cell lysates were immunoprecipi-tated with anti-GFP antibody. IPs and WCLs were analyzed by western blot analysis with anti-ubiquitin, anti-GFP and anti-GAPDH antibodies. Results are representative of 2 experimental repeats. (C) HECTD1 promotes the ubiquitination of SNAIL in vivo. HeLa cells were transfected with expression plasmids for HECTD1 (Halo-HECTD1) and SNAIL (GFP-SNAIL) in the presence of 5 µM MG132 for 16 h. The cell lysates were immunoprecipitated with anti-GFP antibody and analyzed by western blot analysis with anti-ubiquitin antibodies. IP, immunoprecipitates; WCL, whole cell lysates; Ctrl, negative control; KD, knockdown; HECTD1, HECT domain E3 ubiquitin ligase 1.
Article Snippet: Anti-SNAIL (cat. no. 3879), a nt i- SLUG (c at. no. 9585), a nt i-E - c a d he r i n (cat. no. 3195), anti-N-cadherin (cat. no. 4061), anti-ERK1/2 (cat. no. 4695), anti-phospho-ERK1/2 (Thr202/Tyr204; cat. no. 4374) and anti-GAPDH (2118L) primary antibodies were purchased from Cell Signaling Technology, Inc.; the
Techniques: In Vivo, Expressing, Immunoprecipitation, Transfection, Western Blot, Ubiquitin Proteomics, Plasmid Preparation, Negative Control, Knockdown
Journal: International Journal of Oncology
Article Title: HECTD1 regulates the expression of SNAIL: Implications for epithelial-mesenchymal transition
doi: 10.3892/ijo.2020.5002
Figure Lengend Snippet: Subcellular localization of SNAIL. (A) CHX chase assay. HeLa cells were treated with 100 µg/ml CHX for the indicated time period and western blot analysis was performed with an anti-SNAIL antibody. Statistical analysis was performed using the Student's t-test. (B) Subcellular localization of SNAIL was analyzed using fluorescence microscopy in the Ctrl- or HECTD1-KD-transfected cells. The subcellular localization of SNAIL in individual cells is indicated with the arrow-line. Scale bar, 50 µm. (C) SNAIL nuclear signal intensities in Ctrl- and HECTD1-KD cells was examined by staining using anti-SNAIL antibodies. Data are represented as the means ± SD. ** P<0.01 and >50 cells of each cell type was measured. (D) SNAIL nuclear signal in Ctrl- and HECTD1-KD cells with/without epidermal growth factor treatment was analyzed and the percentage of cells exhibiting high levels of nuclear signals are presented. Data are analyzed by one-way ANOVA and represented as the means ± SD. *** P<0.001. Ctrl, negative control; HECTD1, HECT domain E3 ubiquitin ligase 1; KD, knockdown; CHX, cycloheximide.
Article Snippet: Anti-SNAIL (cat. no. 3879), a nt i- SLUG (c at. no. 9585), a nt i-E - c a d he r i n (cat. no. 3195), anti-N-cadherin (cat. no. 4061), anti-ERK1/2 (cat. no. 4695), anti-phospho-ERK1/2 (Thr202/Tyr204; cat. no. 4374) and anti-GAPDH (2118L) primary antibodies were purchased from Cell Signaling Technology, Inc.; the
Techniques: Western Blot, Fluorescence, Microscopy, Transfection, Staining, Negative Control, Ubiquitin Proteomics, Knockdown
Journal: International Journal of Oncology
Article Title: HECTD1 regulates the expression of SNAIL: Implications for epithelial-mesenchymal transition
doi: 10.3892/ijo.2020.5002
Figure Lengend Snippet: HECTD1 translocates between the nucleus and cytoplasm. (A) HECTD1 shuttles between the nucleus and cytoplasm with or without EGF treatment. The subcellular localization of HECTD1 was analyzed using fluorescence microscopy. HeLa cells were treated with or without 100 ng/ml EGF for 6 min and immunostained with anti-HECTD1 antibody. The nucleus was stained with DAPI. The arrow-lines indicate the subcellular localizations of SNAIL, measured as the fluorescent intensity in individual cells. (B) The export of HECTD1 from the nucleus is sensitive to LMB treatment. HeLa cells were treated with or without 50 nM LMB for 4 h and sequentially treated with 100 ng/ml EGF. Cells were stained with anti-HECTD1 antibody and the fluorescent intensity demonstrates HECTD1 localization. Scale bar, 10 µm. (C and D) Intensity of HECTD1 nuclear signals and whole cells were analyzed and semi-quantified, and the percentage of nuclear signals are presented. Data were analyzed by the Student's t-test and presented as the means ± SD. *** P<0.001. LMB, leptomycin-B; EGF, epidermal growth factor; HECTD1, HECT domain E3 ubiquitin ligase 1. Nuclear signals of (E) HECTD1 and (F) SNAIL were analyzed in wild-type Hela cells with not treatment (NT), or with LMB (50 nM) or IVE (1 µM). The percentages of cell nuclear signal are shown. Statistical analysis was performed using one-way ANOVA with Tukey's multiple comparisons post hoc test. The data are shown as the means ± SD. *** P<0.001. (G) Quantification of SNAIL total signal intensities of wild-type cells were analyzed in different treatments. The data analyzed by one-way ANOVA and are shown as the means ± SD. n.s., no significant differences. More than 30 cells in each treatment condition were measured.
Article Snippet: Anti-SNAIL (cat. no. 3879), a nt i- SLUG (c at. no. 9585), a nt i-E - c a d he r i n (cat. no. 3195), anti-N-cadherin (cat. no. 4061), anti-ERK1/2 (cat. no. 4695), anti-phospho-ERK1/2 (Thr202/Tyr204; cat. no. 4374) and anti-GAPDH (2118L) primary antibodies were purchased from Cell Signaling Technology, Inc.; the
Techniques: Fluorescence, Microscopy, Staining, Ubiquitin Proteomics
Journal: International Journal of Oncology
Article Title: HECTD1 regulates the expression of SNAIL: Implications for epithelial-mesenchymal transition
doi: 10.3892/ijo.2020.5002
Figure Lengend Snippet: Knockdown of HECTD1 potentiates EMT. (A) Morphological changes in HeLa cells following HECTD1 knockdown with short hairpin RNA. HeLa cells transfected with Ctrl or HECTD1-KD exhibited an elongated and highly multipolar morphology. In the lower panel, cells were immunostained with an anti-α-tubulin antibody. Scale bar, 50 µm. Percentage of spindle-like phenotype (elongated) over 'cobblestone' phenotype (cubed) of cells were determined in a single experiment. (B) Wound healing assays were performed on fibronectin for 24 h in medium containing 1 µM aphidicolin and cell migration was semi-quantified. Statistical analysis was performed using the Student's t-test. * P<0.05. (C) Transwell migration assays were performed in HECTD1-KD-transfected (FI316530) Ca Ski cells. Results obtained from a single knockdown are presented. Cells in 4 randomly selected fields were counted using a microscope. Statistical analysis was performed using the Student's t-test. ** P<0.01. (D) Western blot analysis for selected EMT markers in Ctrl- or HECTD1-KD-transfected cells following EGF treatment. HeLa cells were treated with 100 ng/ml EGF for 0-120 min following overnight serum starvation. The numbers found below each lane indicate the quantified protein expression following normalization with GAPDH. Ctrl, negative control, HECTD1, HECT domain E3 ubiquitin ligase 1; KD, knockdown; EMT, epithelial-mesenchymal transition; EGF, epidermal growth factor.
Article Snippet: Anti-SNAIL (cat. no. 3879), a nt i- SLUG (c at. no. 9585), a nt i-E - c a d he r i n (cat. no. 3195), anti-N-cadherin (cat. no. 4061), anti-ERK1/2 (cat. no. 4695), anti-phospho-ERK1/2 (Thr202/Tyr204; cat. no. 4374) and anti-GAPDH (2118L) primary antibodies were purchased from Cell Signaling Technology, Inc.; the
Techniques: Knockdown, shRNA, Transfection, Migration, Microscopy, Western Blot, Expressing, Negative Control, Ubiquitin Proteomics
Journal: International Journal of Oncology
Article Title: HECTD1 regulates the expression of SNAIL: Implications for epithelial-mesenchymal transition
doi: 10.3892/ijo.2020.5002
Figure Lengend Snippet: Regulation of HECTD1 expression levels by miR-210 under hypoxic conditions. (A) HeLa cells were treated with 500 µM CoCl 2 to induce hypoxic conditions for the indicated time periods. RT-qPCR was performed to determine the expression levels of mature miR-21/210 and HECTD1 . Each value was normalized to U6 expression levels and is expressed relative to the expression levels of miR-21/miR-210 in HeLa cells treated with the Ctrl. Data were analyzed by one-way ANOVA at 8 h and are presented as the means ± SEM of 3 independent experimental repeats. * P<0.05, *** P<0.001. Relative expression [log 2 (treatment/control)] was quantified by normalizing values to expression levels recorded at 0 h. (B) Effect of the antagomir miR-21/210 transfection in HeLa cells on HECTD1 expression using RT-qPCR. HeLa cells were transfected with miR-21 or miR-210 antagomir or Ctrl for 16 h. Other cells were treated with 500 µM CoCl 2 or 100 ng/ml EGF for 16 h. Expression levels were quantified by normalizing expression levels to cells not exposed to CoCl 2 or EGF. Statistical analysis was performed using unpaired one-way ANOVA. *** P<0.001. RT-qPCR, reverse transcription-quantitative PCR; HECTD1, HECT domain E3 ubiquitin ligase 1; Ctrl, negative control; n.s., not significant; miR, microRNA; EGF, epidermal growth factor.
Article Snippet: Anti-SNAIL (cat. no. 3879), a nt i- SLUG (c at. no. 9585), a nt i-E - c a d he r i n (cat. no. 3195), anti-N-cadherin (cat. no. 4061), anti-ERK1/2 (cat. no. 4695), anti-phospho-ERK1/2 (Thr202/Tyr204; cat. no. 4374) and anti-GAPDH (2118L) primary antibodies were purchased from Cell Signaling Technology, Inc.; the
Techniques: Expressing, Quantitative RT-PCR, Control, Transfection, Reverse Transcription, Real-time Polymerase Chain Reaction, Ubiquitin Proteomics, Negative Control
Journal: International Journal of Oncology
Article Title: HECTD1 regulates the expression of SNAIL: Implications for epithelial-mesenchymal transition
doi: 10.3892/ijo.2020.5002
Figure Lengend Snippet: Analysis of the association of HECTD1 expression levels with clinical outcome in cervical cancer. (A) Schematic representation of the HECTD1 gene and the positions of somatic mutations identified from The Cancer Genome Atlas. (B) Representative immunohistochemical images of HECTD1 (left panel) and SNAIL (right panel) protein expression levels in cervical cancer obtained from the HPA. (C) Low HECTD1 expression levels were associated with a poor survival of patients with cervical cancer. Kaplan-Meier plots presenting the relapse-free survival of cohorts of patients from the HPA. HECTD1 expression levels in patients is negatively correlated with SNAIL expression levels. HPA, Human Protein Atlas; HECTD1, HECT domain E3 ubiquitin ligase 1.
Article Snippet: Anti-SNAIL (cat. no. 3879), a nt i- SLUG (c at. no. 9585), a nt i-E - c a d he r i n (cat. no. 3195), anti-N-cadherin (cat. no. 4061), anti-ERK1/2 (cat. no. 4695), anti-phospho-ERK1/2 (Thr202/Tyr204; cat. no. 4374) and anti-GAPDH (2118L) primary antibodies were purchased from Cell Signaling Technology, Inc.; the
Techniques: Expressing, Immunohistochemical staining, Ubiquitin Proteomics
Journal: Therapeutic Advances in Chronic Disease
Article Title: CircHECTD1 mediates pulmonary fibroblast activation via HECTD1
doi: 10.1177/2040622319891558
Figure Lengend Snippet: HECTD1 expression was induced in HPF-a cells after exposure to silica and increased in fibroblasts derived from patients with silicosis. (a) Representative western blot showing SiO 2 -induced HECTD1 upregulation in a time-dependent manner. (b) Densitometric analysis of HECTD1 from five experiments; * p < 0.05 versus the control group; n = 5. (c) Representative images of immunocytochemical staining showing that SiO 2 (50 mg/cm 2 ) increased the HECTD1 protein in HPF-a cells 6 h after the initiation of SiO 2 treatment. Scale bar = 50 μm. (d) Immunohistochemistry of the fibroblast marker vimentin and HECTD1 protein in the lung tissues of mice exposed to NS or SiO 2 . Colocalization of vimentin and HECTD1 protein is shown. The images are representative of several individuals from each group. Scale bar = 20 μm. (e) Representative images of immunohistochemical staining show the expression of vimentin and HECTD1 in lung sections from healthy donors and patients with silicosis. Scale bar = 20 μm. HECTD1, domain-containing E3 ubiquitin protein ligase 1; NS, normal saline; SiO 2 , silicon dioxide.
Article Snippet:
Techniques: Expressing, Derivative Assay, Western Blot, Staining, Immunohistochemistry, Marker, Immunohistochemical staining
Journal: Therapeutic Advances in Chronic Disease
Article Title: CircHECTD1 mediates pulmonary fibroblast activation via HECTD1
doi: 10.1177/2040622319891558
Figure Lengend Snippet: HECTD1 regulates fibroblast proliferation and activation in HPF-a cells. (a) MTT assay showing that the SiO 2 -induced increase in cell viability was reversed by HECTD1 knockdown; * p < 0.05 versus the corresponding control group; # p < 0.05 versus the SiO 2 group; n = 5. (b) Representative images of collagen gel sizes showing the effects of SiO 2 on gel contraction (indicating fibroblast activation). (c) Quantification of the matrix area in five separate experiments. * p < 0.05 versus the corresponding control group; # p < 0.05 versus the SiO 2 group. (d) Immunofluorescence for BrdU (green) and DAPI (blue). Merged image demonstrating that proliferation induced by SiO 2 was attenuated by HECTD1 knockdown. Scale bar = 50 μm. (e) Percent of BrdU-positive cells from five separate experiments. * p < 0.05 versus the corresponding control group; # p < 0.05 versus the SiO 2 group. (f) Representative western blot showing the effects of HECTD1-NIC transfection on SiO 2 -induced BAX and BCL-XL expression in HPF-a cells. (g) Densitometric analyses of five separate experiments suggested that BAX expression was enhanced by HECTD1-NIC transfection, but BCL-XL expression was decreased. * p < 0.05 versus the corresponding control group; # p < 0.05 versus the SiO 2 group. (h) Representative images of Hoechst 33342 staining depicting apoptosis of HPF-a cells was enhanced by HECTD1-NIC. Scale bar = 50 μm. (i) Percentages of apoptotic cells from five independent experiments are presented. * p < 0.05 versus the control group. # p < 0.05 versus the SiO 2 group. BrdU, bromodeoxyuridine; DAPI, 4′,6-diamidino-2-phenylindole; HECTD1, domain-containing E3 ubiquitin protein ligase 1; MTT, (4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; NS, normal saline; SiO 2 , silicon dioxide.
Article Snippet:
Techniques: Activation Assay, MTT Assay, Immunofluorescence, Western Blot, Transfection, Expressing, Staining
Journal: Therapeutic Advances in Chronic Disease
Article Title: CircHECTD1 mediates pulmonary fibroblast activation via HECTD1
doi: 10.1177/2040622319891558
Figure Lengend Snippet: HECTD1 mediates silica-induced cell migration in HPF-a cells. (a) Representative images showing the SiO 2 -induced increase in cell migration using a scratch assay was attenuated by HECTD1-NIC. Scale bar = 50 μm. (b) Quantification of the scratch gap distances from five independent experiments; * p < 0.05 versus the corresponding time point in the control group; # p < 0.05 versus the corresponding time point in the SiO 2 group. (c) Representative images of SiO 2 -induced cell migration in a nested gel matrix; this migration was abolished by HECTD1-NIC. Scale bar = 50 μm. Quantification of the number of migrated cells (white arrows) from the nested gel matrix (d) and the maximum migrated distance (red arrows) (e) from five separate experiments. * p < 0.05 versus the corresponding time point in the control group; # p < 0.05 versus the corresponding time point in the SiO 2 group. (f,h) Representative western blot showing that SiO 2 -induced phosphorylation of PYK2 occurred in a time-dependent manner and was attenuated by HECTD1-NIC. (g,i) Densitometric analysis of the phosphorylation of PYK2 expression from five experiments; * p < 0.05 versus the control group; # p < 0.05 versus the corresponding time point in the SiO 2 group. HECTD1, domain-containing E3 ubiquitin protein ligase 1; SiO 2 , silicon dioxide.
Article Snippet:
Techniques: Migration, Wound Healing Assay, Western Blot, Expressing
Journal: Therapeutic Advances in Chronic Disease
Article Title: CircHECTD1 mediates pulmonary fibroblast activation via HECTD1
doi: 10.1177/2040622319891558
Figure Lengend Snippet: HECTD1 mediates autophagic processes in fibroblasts exposed to silica. (a) Representative western blot showing the effects of SiO 2 on the expression of the autophagy markers ATG5, BECN and LC3B in HPF-a cells. (b) Densitometric analyses of five separate experiments suggested that SiO 2 induced increases in ATG5, BECN and LC3B expression. * p < 0.05 versus ATG5 expression at 0 h; # p < 0.05 versus BECN expression at 0 h; $ p < 0.05 versus LC3B expression at 0 h; (c) Representative western blot showing the effects of HECTD1 knockdown on the SiO 2 -induced expression of ATG5, BECN and LC3B in HPF-a cells at 6 h following 50 μg/cm 2 SiO 2 treatment. (d) Densitometric analyses of five separate experiments suggested that HECTD1-NIC attenuated the SiO 2 -induced increases in ATG5, BECN and LC3B expression. * p < 0.05 versus the control group; # p < 0.05 versus the corresponding SiO 2 group. (e) Representative images showing the effects of HECTD1-NIC on the SiO 2 -induced formation of RFP- and GFP-MAP1LC3 puncta at 6 h following SiO 2 treatment. Scale bar = 10 μm. Red arrows indicate autolysosomes; yellow arrows indicate autophagosomes. (f) Quantification of the RFP- and GFP- MAP1LC3 puncta demonstrating that SiO 2 -induced autophagy was attenuated by HECTD1 NIC. * p < 0.05 versus the Con-NIC group; (g) Quantification of RFP-MAP1LC3 puncta and RFP- and GFP-colocalized puncta demonstrating autophagic flux induced by SiO 2 was attenuated by HECTD1-NIC. * p < 0.05 versus the Con-NIC group. HECTD1, domain-containing E3 ubiquitin protein ligase 1; SiO 2 , silicon dioxide.
Article Snippet:
Techniques: Western Blot, Expressing
Journal: Therapeutic Advances in Chronic Disease
Article Title: CircHECTD1 mediates pulmonary fibroblast activation via HECTD1
doi: 10.1177/2040622319891558
Figure Lengend Snippet: HECTD1-mediated autophagy regulates activation and migration in HPF-a cells. (a) Representative images showing that HECTD1 knockdown inhibited cell migration, which was reversed by pretreatment with rapamycin (5 μg/μl). Scale bar = 50 μm. (b) Quantification of the scratch gap distance from five separate experiments. * p < 0.05 versus the Con-NIC group at the corresponding time points. # p < 0.05 versus the HECTD1-NIC group at the corresponding time points. (c) MTT assay showing that HECTD1 knockdown inhibited cell viability and was reversed by pretreatment with rapamycin. * p < 0.05 versus the corresponding control group; n = 5. HECTD1, domain-containing E3 ubiquitin protein ligase 1; MTT, (4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; SiO 2 , silicon dioxide.
Article Snippet:
Techniques: Activation Assay, Migration, MTT Assay
Journal: Therapeutic Advances in Chronic Disease
Article Title: CircHECTD1 mediates pulmonary fibroblast activation via HECTD1
doi: 10.1177/2040622319891558
Figure Lengend Snippet: Expression of circHECTD1 in fibroblasts after SiO 2 treatment. (a) qRT-PCR analysis showing the expression of HECTD1 mRNA did not change after HPF-a cells were exposed to SiO 2 ; * p < 0.05 versus 0 h; n = 5. (b) Structures and probe sequence of circHECTD1, as well as ID number and alias of hsa_circ_0101590 from the circBase database. (c) As shown in the qRT-PCR analysis, circHECTD1 expression in HPF-a cells was decreased after exposure to SiO 2 ; * p < 0.05 versus circHECTD1 expression at 0 h; n = 5. (d) FISH assay showing circHECTD1 expression in HPF-a cells exposed to SiO 2 . circHECTD1 was labeled with fluorescein isothiocyanate, and immunocytochemical staining showed that SiO 2 increased the HECTD1 protein expression in HPF-a cells. Scale bar = 20 μm. HECTD1, domain-containing E3 ubiquitin protein ligase 1; FISH, fluorescence in situ hybridization; qRT-PCR, quantitative real-time PCR; SiO 2 , silicon dioxide.
Article Snippet:
Techniques: Expressing, Quantitative RT-PCR, Sequencing, Labeling, Staining, Fluorescence, In Situ Hybridization, Real-time Polymerase Chain Reaction
Journal: Therapeutic Advances in Chronic Disease
Article Title: CircHECTD1 mediates pulmonary fibroblast activation via HECTD1
doi: 10.1177/2040622319891558
Figure Lengend Snippet: circHECTD1 is involved in SiO 2 -induced HECTD1 upregulation and affects the function of cells. (a) As shown in the qRT-PCR analysis, transfection of the circHECTD1 lentivirus upregulated circHECTD1 expression in HPF-a cells. ** p < 0.01; n = 5. (b) Representative western blot showing the effect of specific overexpression of circHECTD1 with lentivirus on SiO 2 -induced HECTD1 expression. (c) Densitometric analyses of five separate experiments suggested that SiO 2 -induced changes in HECTD1 expression are attenuated by circHECTD1 upregulation. * p < 0.05 versus the levels of the corresponding protein in the control group; # P <0.05 vs. the levels of the corresponding protein in the SiO 2 group. (d) qRT-PCR analysis showing that the expression of the Hectd1 mRNA did not change in HPF-a cells after overexpression of circHECTD1; n = 5. (e) Representative images showing that the effect of SiO 2 on GFP-labeled HPF-a cell migration in scratch assays was attenuated by circHECTD1 overexpression. Scale bar = 50 µm. (f) Quantification of the scratch gap distances in five separate experiments. * p < 0.05 versus the control group; # p < 0.05 versus the SiO 2 group. (g) MTT assay showing that the SiO 2 -induced increase in cell viability was reversed by circHECTD1 overexpression; * p < 0.05 versus the control group; # p < 0.05 versus the SiO 2 group; n = 5. HECTD1, domain-containing E3 ubiquitin protein ligase 1; MTT, (4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; qRT-PCR, quantitative real-time PCR; SiO 2 , silicon dioxide.
Article Snippet:
Techniques: Quantitative RT-PCR, Transfection, Expressing, Western Blot, Over Expression, Labeling, Migration, MTT Assay, Real-time Polymerase Chain Reaction
Journal: Therapeutic Advances in Chronic Disease
Article Title: CircHECTD1 mediates pulmonary fibroblast activation via HECTD1
doi: 10.1177/2040622319891558
Figure Lengend Snippet: Schematic diagram showing the mechanisms by which circHECTD1/HECTD1 mediates SiO 2 -induced pulmonary fibrosis. HECTD1, domain-containing E3 ubiquitin protein ligase 1; SiO 2 , silicon dioxide.
Article Snippet:
Techniques:
Journal: International Journal of Oncology
Article Title: HECTD1 regulates the expression of SNAIL: Implications for epithelial-mesenchymal transition
doi: 10.3892/ijo.2020.5002
Figure Lengend Snippet: Interaction of HECTD1 with SNAIL. (A) In vivo interaction of HECTD1 with SNAIL. The interaction between HECTD1 and SNAIL expression levels were investigated using Co-Immunoprecipitation. HeLa cells were transfected with GFP-tagged SNAIL or GFP for 24 h, followed by sequential treatment with DMSO or 5 µM MG132 for 16 h. The cell lysates were immunoprecipitated with anti-GFP. IPs and WCLs were analyzed using western blotting to detect the expression levels of HECTD1 and GFP. (B) SNAIL ubiquitination assay. HeLa Ctrl and HECTD1-KD cells were transiently transfected with GFP-SNAIL or GFP empty vector for 24 h, followed by sequential treatment with DMSO or 5 µM MG132 for 16 h. The cell lysates were immunoprecipi-tated with anti-GFP antibody. IPs and WCLs were analyzed by western blot analysis with anti-ubiquitin, anti-GFP and anti-GAPDH antibodies. Results are representative of 2 experimental repeats. (C) HECTD1 promotes the ubiquitination of SNAIL in vivo. HeLa cells were transfected with expression plasmids for HECTD1 (Halo-HECTD1) and SNAIL (GFP-SNAIL) in the presence of 5 µM MG132 for 16 h. The cell lysates were immunoprecipitated with anti-GFP antibody and analyzed by western blot analysis with anti-ubiquitin antibodies. IP, immunoprecipitates; WCL, whole cell lysates; Ctrl, negative control; KD, knockdown; HECTD1, HECT domain E3 ubiquitin ligase 1.
Article Snippet: Different clones of the
Techniques: In Vivo, Expressing, Immunoprecipitation, Transfection, Western Blot, Ubiquitin Proteomics, Plasmid Preparation, Negative Control, Knockdown
Journal: International Journal of Oncology
Article Title: HECTD1 regulates the expression of SNAIL: Implications for epithelial-mesenchymal transition
doi: 10.3892/ijo.2020.5002
Figure Lengend Snippet: Subcellular localization of SNAIL. (A) CHX chase assay. HeLa cells were treated with 100 µg/ml CHX for the indicated time period and western blot analysis was performed with an anti-SNAIL antibody. Statistical analysis was performed using the Student's t-test. (B) Subcellular localization of SNAIL was analyzed using fluorescence microscopy in the Ctrl- or HECTD1-KD-transfected cells. The subcellular localization of SNAIL in individual cells is indicated with the arrow-line. Scale bar, 50 µm. (C) SNAIL nuclear signal intensities in Ctrl- and HECTD1-KD cells was examined by staining using anti-SNAIL antibodies. Data are represented as the means ± SD. ** P<0.01 and >50 cells of each cell type was measured. (D) SNAIL nuclear signal in Ctrl- and HECTD1-KD cells with/without epidermal growth factor treatment was analyzed and the percentage of cells exhibiting high levels of nuclear signals are presented. Data are analyzed by one-way ANOVA and represented as the means ± SD. *** P<0.001. Ctrl, negative control; HECTD1, HECT domain E3 ubiquitin ligase 1; KD, knockdown; CHX, cycloheximide.
Article Snippet: Different clones of the
Techniques: Western Blot, Fluorescence, Microscopy, Transfection, Staining, Negative Control, Ubiquitin Proteomics, Knockdown
Journal: International Journal of Oncology
Article Title: HECTD1 regulates the expression of SNAIL: Implications for epithelial-mesenchymal transition
doi: 10.3892/ijo.2020.5002
Figure Lengend Snippet: HECTD1 translocates between the nucleus and cytoplasm. (A) HECTD1 shuttles between the nucleus and cytoplasm with or without EGF treatment. The subcellular localization of HECTD1 was analyzed using fluorescence microscopy. HeLa cells were treated with or without 100 ng/ml EGF for 6 min and immunostained with anti-HECTD1 antibody. The nucleus was stained with DAPI. The arrow-lines indicate the subcellular localizations of SNAIL, measured as the fluorescent intensity in individual cells. (B) The export of HECTD1 from the nucleus is sensitive to LMB treatment. HeLa cells were treated with or without 50 nM LMB for 4 h and sequentially treated with 100 ng/ml EGF. Cells were stained with anti-HECTD1 antibody and the fluorescent intensity demonstrates HECTD1 localization. Scale bar, 10 µm. (C and D) Intensity of HECTD1 nuclear signals and whole cells were analyzed and semi-quantified, and the percentage of nuclear signals are presented. Data were analyzed by the Student's t-test and presented as the means ± SD. *** P<0.001. LMB, leptomycin-B; EGF, epidermal growth factor; HECTD1, HECT domain E3 ubiquitin ligase 1. Nuclear signals of (E) HECTD1 and (F) SNAIL were analyzed in wild-type Hela cells with not treatment (NT), or with LMB (50 nM) or IVE (1 µM). The percentages of cell nuclear signal are shown. Statistical analysis was performed using one-way ANOVA with Tukey's multiple comparisons post hoc test. The data are shown as the means ± SD. *** P<0.001. (G) Quantification of SNAIL total signal intensities of wild-type cells were analyzed in different treatments. The data analyzed by one-way ANOVA and are shown as the means ± SD. n.s., no significant differences. More than 30 cells in each treatment condition were measured.
Article Snippet: Different clones of the
Techniques: Fluorescence, Microscopy, Staining, Ubiquitin Proteomics
Journal: International Journal of Oncology
Article Title: HECTD1 regulates the expression of SNAIL: Implications for epithelial-mesenchymal transition
doi: 10.3892/ijo.2020.5002
Figure Lengend Snippet: Knockdown of HECTD1 potentiates EMT. (A) Morphological changes in HeLa cells following HECTD1 knockdown with short hairpin RNA. HeLa cells transfected with Ctrl or HECTD1-KD exhibited an elongated and highly multipolar morphology. In the lower panel, cells were immunostained with an anti-α-tubulin antibody. Scale bar, 50 µm. Percentage of spindle-like phenotype (elongated) over 'cobblestone' phenotype (cubed) of cells were determined in a single experiment. (B) Wound healing assays were performed on fibronectin for 24 h in medium containing 1 µM aphidicolin and cell migration was semi-quantified. Statistical analysis was performed using the Student's t-test. * P<0.05. (C) Transwell migration assays were performed in HECTD1-KD-transfected (FI316530) Ca Ski cells. Results obtained from a single knockdown are presented. Cells in 4 randomly selected fields were counted using a microscope. Statistical analysis was performed using the Student's t-test. ** P<0.01. (D) Western blot analysis for selected EMT markers in Ctrl- or HECTD1-KD-transfected cells following EGF treatment. HeLa cells were treated with 100 ng/ml EGF for 0-120 min following overnight serum starvation. The numbers found below each lane indicate the quantified protein expression following normalization with GAPDH. Ctrl, negative control, HECTD1, HECT domain E3 ubiquitin ligase 1; KD, knockdown; EMT, epithelial-mesenchymal transition; EGF, epidermal growth factor.
Article Snippet: Different clones of the
Techniques: Knockdown, shRNA, Transfection, Migration, Microscopy, Western Blot, Expressing, Negative Control, Ubiquitin Proteomics
Journal: International Journal of Oncology
Article Title: HECTD1 regulates the expression of SNAIL: Implications for epithelial-mesenchymal transition
doi: 10.3892/ijo.2020.5002
Figure Lengend Snippet: Regulation of HECTD1 expression levels by miR-210 under hypoxic conditions. (A) HeLa cells were treated with 500 µM CoCl 2 to induce hypoxic conditions for the indicated time periods. RT-qPCR was performed to determine the expression levels of mature miR-21/210 and HECTD1 . Each value was normalized to U6 expression levels and is expressed relative to the expression levels of miR-21/miR-210 in HeLa cells treated with the Ctrl. Data were analyzed by one-way ANOVA at 8 h and are presented as the means ± SEM of 3 independent experimental repeats. * P<0.05, *** P<0.001. Relative expression [log 2 (treatment/control)] was quantified by normalizing values to expression levels recorded at 0 h. (B) Effect of the antagomir miR-21/210 transfection in HeLa cells on HECTD1 expression using RT-qPCR. HeLa cells were transfected with miR-21 or miR-210 antagomir or Ctrl for 16 h. Other cells were treated with 500 µM CoCl 2 or 100 ng/ml EGF for 16 h. Expression levels were quantified by normalizing expression levels to cells not exposed to CoCl 2 or EGF. Statistical analysis was performed using unpaired one-way ANOVA. *** P<0.001. RT-qPCR, reverse transcription-quantitative PCR; HECTD1, HECT domain E3 ubiquitin ligase 1; Ctrl, negative control; n.s., not significant; miR, microRNA; EGF, epidermal growth factor.
Article Snippet: Different clones of the
Techniques: Expressing, Quantitative RT-PCR, Control, Transfection, Reverse Transcription, Real-time Polymerase Chain Reaction, Ubiquitin Proteomics, Negative Control
Journal: International Journal of Oncology
Article Title: HECTD1 regulates the expression of SNAIL: Implications for epithelial-mesenchymal transition
doi: 10.3892/ijo.2020.5002
Figure Lengend Snippet: Analysis of the association of HECTD1 expression levels with clinical outcome in cervical cancer. (A) Schematic representation of the HECTD1 gene and the positions of somatic mutations identified from The Cancer Genome Atlas. (B) Representative immunohistochemical images of HECTD1 (left panel) and SNAIL (right panel) protein expression levels in cervical cancer obtained from the HPA. (C) Low HECTD1 expression levels were associated with a poor survival of patients with cervical cancer. Kaplan-Meier plots presenting the relapse-free survival of cohorts of patients from the HPA. HECTD1 expression levels in patients is negatively correlated with SNAIL expression levels. HPA, Human Protein Atlas; HECTD1, HECT domain E3 ubiquitin ligase 1.
Article Snippet: Different clones of the
Techniques: Expressing, Immunohistochemical staining, Ubiquitin Proteomics
Journal: Cell Death & Disease
Article Title: circHECTD1 promotes the silica-induced pulmonary endothelial–mesenchymal transition via HECTD1
doi: 10.1038/s41419-018-0432-1
Figure Lengend Snippet: a In the SiO 2 -induced EndMT, circHECTD1 may regulate the expression of its host gene, hectd1 . b As shown in the qRT-PCR analysis, levels of the hectd1 mRNA did not change in MML1 cells exposed to SiO 2 ( n = 5). c Representative western blot showing the effect of SiO 2 on the level of the HECTD1 protein. d Densitometric analyses of five separate experiments suggest that SiO 2 increases the level of the HECTD1 protein in MML1 cells. * P < 0.05 vs. protein expression at 0 h. e As shown in the qRT-PCR analysis, the expression of the hectd1 mRNA decreased in MML1 cells treated with circHECTD1-siRNA. * P < 0.05 vs. the control group, n = 5. f Representative western blot showing the effect of specific knockdown of circHECTD1 with siRNAs on SiO 2 -induced HECTD1 expression. g Densitometric analyses of five separate experiments suggest that SiO 2 -induced changes in HECTD1 expression are attenuated by circHECTD1-siRNA. * P < 0.05 vs. the levels of the corresponding protein in the control group; # P < 0.05 vs. the levels of the corresponding protein in the SiO 2 group
Article Snippet: The
Techniques: Expressing, Quantitative RT-PCR, Western Blot, Control, Knockdown
Journal: Cell Death & Disease
Article Title: circHECTD1 promotes the silica-induced pulmonary endothelial–mesenchymal transition via HECTD1
doi: 10.1038/s41419-018-0432-1
Figure Lengend Snippet: a Representative western blot and densitometric analyses showing the efficacy of HECTD1 CRISPR ACT at increasing the level of the HECTD1 protein. * P < 0.05 vs. the control group, n = 5. b Representative western blot showing the effect of specific upregulation of HECTD1 expression with ACT on SiO 2 -induced endothelial marker expression. c Densitometric analyses of five separate experiments suggest that the SiO 2 -induced changes in VE-Cad/Cdh-5 levels, but not PECAM 1/CD31 levels, are attenuated by HECTD1 ACT. * P < 0.05 vs. the level of the corresponding protein in the control group; # P < 0.05 vs. the level of the corresponding protein in the SiO 2 group. d Representative western blot showing the effect of specific upregulation of HECTD1 with ACT on SiO 2 -induced mesenchymal marker expression. e Densitometric analyses of five separate experiments suggest that the SiO 2 -induced changes in mesenchymal markers are attenuated by HECTD1 ACT. * P < 0.05 vs. the level of the corresponding protein in the control group; # P < 0.05 vs. the level of the corresponding protein in the SiO 2 group. f Representative images of immunocytochemical staining show that SiO 2 -induced α-SMA/Acta2 expression was attenuated by HECTD1 ACT
Article Snippet: The
Techniques: Western Blot, CRISPR, Control, Expressing, Marker, Staining
Journal: Cell Death & Disease
Article Title: circHECTD1 promotes the silica-induced pulmonary endothelial–mesenchymal transition via HECTD1
doi: 10.1038/s41419-018-0432-1
Figure Lengend Snippet: a MTT assay showing that HECTD1 ACT attenuated the SiO 2 -induced increase in MML1 cell viability. * P < 0.05 vs. the control group; # P < 0.05 vs. the SiO 2 group, n = 5. b Representative images show that the effect of SiO 2 on GFP-labeled MML1 cell migration in scratch assays was attenuated by HECTD1 ACT. Scale bar = 80 µm. c Quantification of the scratch gap distances in six separate experiments. * P < 0.05 vs. the control group; # P < 0.05 vs. the SiO 2 group. d Representative images show that the effect of SiO 2 on GFP-labeled MML1 cell migration in the nested matrix cell migration assay was attenuated by HECTD1 ACT. Scale bar = 80 µm
Article Snippet: The
Techniques: MTT Assay, Control, Labeling, Migration, Cell Migration Assay
Journal: Cell Death & Disease
Article Title: circHECTD1 promotes the silica-induced pulmonary endothelial–mesenchymal transition via HECTD1
doi: 10.1038/s41419-018-0432-1
Figure Lengend Snippet: a Representative images of immunohistochemical staining show that Tie2-GFP co-localization with HECTD1 decreased in TEK-GFP 287 Sato/JNju mice treated with SiO 2 . b Representative images of immunohistochemical staining show the expression patterns of PECAM 1/CD31 and HECTD1 in lung sections from healthy donors and patients with silicosis
Article Snippet: The
Techniques: Immunohistochemical staining, Staining, Expressing
Journal: Cell Death & Disease
Article Title: circHECTD1 promotes the silica-induced pulmonary endothelial–mesenchymal transition via HECTD1
doi: 10.1038/s41419-018-0432-1
Figure Lengend Snippet: circHECTD1 expression is increased in endothelial cells exposed to SiO 2 . The increased expression leads to a subsequent decrease in HECTD1 expression, which, in turn, increases the levels of mesenchymal markers and decreases the levels of endothelial markers. Endothelial cell proliferation and migration are triggered, thereby contributing to irreversible fibrosis in patients with silicosis
Article Snippet: The
Techniques: Expressing, Migration